Evidence map›Paper›PMID 25644705›Full record

ArticleAnalytical biochemistry2015

T(3): targeted proteomics of DNA-binding proteins.

Linda I Nagore, Harry W Jarrett

Open access · greenAbstract read
In one paragraph

Article in Analytical biochemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Linda I NagoreDepartment of Chemistry, University of Texas at San Antonio, San Antonio, TX 78249, USA.
Harry W JarrettDepartment of Chemistry, University of Texas at San Antonio, San Antonio, TX 78249, USA. Electronic address: harry.jarrett@utsa.edu.
The University of Texas at San Antonio · US

Funding

UTSA RISE Research Training ProgramR25GM060655 · NIGMS · UNIVERSITY OF TEXAS SAN ANTONIO · PI BAREA-RODRIGUEZ, EDWIN J · 2000 to 2022
$21.6M
STRUCTURAL VISUALIZATION IN BIOINFORMATICSG12RR013646 · NCRR · UNIVERSITY OF TEXAS SAN ANTONIO · PI JOSE-YACAMAN, MIGUEL · 1998 to 2011
$19.6M
RCMI Center for Interdiscplinary Health Research CIHRG12MD007591 · NIMHD · UNIVERSITY OF TEXAS SAN ANTONIO · PI PERRY, GEORGE · 2012 to 2016
$10.4M
POLYNUCLEOTIDE HIGH-PERFORMANCE AFFINITY CHROMATOGRAPHYR01GM043609 · NIGMS · UNIVERSITY OF TEXAS SAN ANTONIO · PI JARRETT, HARRY W · 1989 to 2013
$3.1M
NCRR NIH HHS G12 RR013646NIGMS NIH HHS GM060655NIGMS NIH HHS R01 GM043609NIGMS NIH HHS R25 GM060655NIMHD NIH HHS G12 MD007591NIMHD NIH HHS G12MD007591
6 · The paper itself

Abstract

A technique that allows the inclusion of a specific DNA to enrich and direct proteomic identification of transcription factors (TFs) while providing a route for high-throughput screening on a single platform would be valuable in investigations of gene expression and regulation. Polyvinylpyrrolidone binds DNA avidly while binding negligible amounts of protein. This observation is used in a proof-of-concept method to enrich for TFs by combining nuclear extract with a specific DNA sequence and immobilizing the DNA-protein complex on a polyvinylpyrrolidone (PVP)-coated MALDI (matrix-assisted laser desorption/ionization) plate. Any unbound proteins are washed away and further processed for analysis in a MALDI-TOF/TOF (tandem time-of-flight) mass spectrometer. Enrichment on a PVP-coated plate gives the unique advantage of purification, enzymatic digestion, and analysis on a single platform. The method is termed T(3) because it combines Targeted purification on a Target plate with Targeted proteomics. Validation was achieved in model experiments with a chimeric fusion protein, green fluorescent protein-CAAT enhancer binding protein (GFP-C/EBP), with an oligonucleotide containing the CAAT sequence. Both domains were identified with an expectation value of less than 10(-15) and more than 15% sequence coverage. The same oligonucleotide mixed with HEK293 cell nuclear extract allowed the unambiguous identification of native human C/EBP alpha with 24.3% sequence coverage.

Indexed as

Amino Acid SequenceAnimalsBase SequenceCattleCCAAT-Enhancer-Binding ProteinsCell ExtractsCell NucleusDNADNA-Binding ProteinsGreen Fluorescent ProteinsHumansMass SpectrometryMolecular Sequence DataPovidoneProtein BindingProteomicsCCAAT-Enhancer-Binding ProteinsCell ExtractsDNADNA-Binding ProteinsGreen Fluorescent ProteinsPovidoneSerum Albumin, BovineDNA-binding proteinsMALDI–MSMass spectrometryProteomicsTranscription factors

Identifiers

PMID25644705
PMCPMC4357572
OpenAlexW2053026914

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.